Mr. Lappe has served as our Chief Executive Officer and as a member of our Board of Directors since January 2024 and prior to that, co-founded the Former Parent in 2010 and served as its Chief Executive Officer and chairman of the board of directors from its inception to May 2024. Mr. Lappe has extensive expertise in the biotechnology industry with over thirty years of experience in executive management, investment management and executive recruiting, having built the executive teams of over forty start-up biotechnology and medical device companies. Prior to founding Inhibrx, Mr. Lappe was the founder and Managing Partner of Efficacy Biotech Fund, a fund focused on strategic investment in public biotechnology companies. We believe Mr. Lappe s service as our co-founder and Chief Executive Officer and his extensive experience in the biotechnology and biotherapeutic industries qualifies him to serve on our Board.